Blood test shows promise for predicting treatment response in patients with advanced HPV-positive throat cancer

By | June 24, 2021
A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.